Most Popular

Janney Montgomery Pounds The Table On BioDelivery Sciences International, Inc. (BDSI)

Janney Montgomery’s healthcare analyst Chiara Russo was out pounding the table on BioDelivery Sciences International, Inc. (NASDAQ:BDSI), reiterating a Buy rating and price target of …

Here’s Why Cantor Increased Price Target for Cisco Systems, Inc.

In a research report issued today, Cantor analyst Brian White maintained a Buy rating on shares of Cisco Systems, Inc. (NASDAQ:CSCO) and slightly raised …

WBB Securities Raises Price Target For Sarepta Therapeutics Inc (SRPT) Ahead Of Eteplirsen FDA Decision

In a research report released today, WBB Securities analyst Stephen Brozak reiterated a Buy rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), and raised …

Alibaba Group Holding Ltd (BABA) Reports Mixed Results: Analysts Remain Bullish For the Long-Term

Chinese e-commerce giant, Alibaba Group Holding Ltd (NYSE:BABA), posted disappointing earnings results yesterday, August 12. Shares slid -6.

Cowen Remains Neutral on Sarepta Therapeutics Inc Following 2Q:15 Results

Cowen’s healthcare analyst Phil Nadeau came out with some commentary on Sarepta Therapeutics Inc (NASDAQ:SRPT), after the company released its second-quarter results and provided update on its …

Wedbush Reduces Price Target For XOMA Corp Due To Pipeline Refocus

In a research report released Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Xoma Corp (NASDAQ:XOMA), while reducing the price …

Canaccord Offers Commentary On Brookfield Asset Management Inc (BAM) Following 2Q:15 Results

In a research report released today, Canaccord analyst Mark Rothschild provided commentary and analysis on the second-quarter earnings results of Brookfield Asset Management Inc (NYSE:BAM), which were …

Needham Reiterates Buy On Intercept Pharmaceuticals Inc Following 2Q:15 Update

Needham’s healthcare analyst Alan Carr came out with some commentary on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company reported second-quarter results and held a conference call …

The Case for Buying Groupon Inc Into Earnings: Brean Capital

Brean Capital analyst Tom Forte weighed in today with an optimistic view on Groupon Inc (NASDAQ:GRPN), as the daily deals company is scheduled …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts